Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basigin, also known as CD147 or EMMPRIN, is a highly glycosylated type I transmembrane protein belonging to the immunoglobulin superfamily. It plays diverse roles in normal physiology, including spermatogenesis, embryo implantation, neural development, and cone photoreceptor survival. It is also involved in various disease states, such as cancer metastasis, malaria, and HIV infection, making it a potential therapeutic target.
Not applicable; Basigin is a target itself, not a drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basigin (BSG).